Open Access Open Badges Research article

A prospective controlled study: minimally invasive stereotactic puncture therapy versus conventional craniotomy in the treatment of acute intracerebral hemorrhage

Houguang Zhou1, Yu Zhang1, Ling Liu2, Xu Han3, Yinghong Tao4, Yuping Tang3, Wei Hua5, Jianzhong Xue6 and Qiang Dong3*

Author Affiliations

1 Department of Geriatrics, Huashan Hospital, Fudan University, Shanghai, China

2 Department of Neurology, Jinling Hospital, Nanjing University Medicine School, Nanjing, China

3 Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China

4 Department of General Medicine, Ouyang Hospital, Hongkou District, Shanghai, China

5 Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China

6 Department of Neurology,Affiliated ChangShu Hospital, Yangzhou University, Changshu, China

For all author emails, please log on.

BMC Neurology 2011, 11:76  doi:10.1186/1471-2377-11-76

The electronic version of this article is the complete one and can be found online at:

Received:24 October 2010
Accepted:13 June 2011
Published:23 June 2011

© 2011 Zhou et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.



Spontaneous intracerebral hemorrhage (ICH) is a devastating form of stroke with the high mortality twofold to sixfold higher than that for ischemic stroke. But the treatment of haematomas within the basal ganglia continues to be a matter of debate among neurologists and neurosurgeons. The purpose of this study is to judge the short-term and long-term clinical value of minimally invasive stereotactic puncture therapy (MISPT) on acute ICH.


A prospective controlled study was undertaken. The clinical trial was in compliance with the WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. According to the enrollment criterion, there were 168 acute ICH cases analyzed, of which 90 cases were performed by MISPT (MISPT group, MG) and 78 cases by Conventional craniotomy (CC group, CG), by means of compare of short-term outcome such as Glasgow Coma Scale (GCS) score, postoperative complications (PC) and rebleeding incidence (RI), moreover, long-term outcome of 1 year postoperation judged by Glasgow Outcome Scale (GOS), Barthel Index (BI), modified Rankin Scale (mRS) and case fatality (CF).


GCS score of MG patients showed obvious amelioration when compared with that of CG (P = 0.039). The PC incidence of in MG decreased obviously compared with that of CG (P = 0.000). The incidences of rebleeding in MG and CG were 10.0% and 15.4% respectively (P = 0.293). There was no obvious difference between CFs of MG and CG. For three parameters representing long-term outcome,the GOS, BI and mRS in MG were ameliorated significantly than that of CG (P = 0.043, P = 0.011 and P = 0.042 respectively).


These data indicated that compared with CC, the advantage of MISPT was not only displayed in short-term outcome such as minute trauma and safety, but also seemed to be feasible and had a trend towards improved long-term outcome such as the GOS,BI and mRS.

Trial Registration

The Australian New Zealand Clinical Trials Registry (ANZCTR), the registration number:ACTRN12610000945022.


Acute intracerebral hemorrhage (AICH) is a devastating form of stroke with the higher mortality and lower survival rate [1,2]. With the highest mortality among all forms of cerebrovascular diseases, about half of the deaths following ICH occur in the first 2 days. After initial irreversible tissue injury happening near the hemorrhage nidus, a progressive cascade of elevated local pressures, edema, and excitotoxicity causes more serious secondary injury to surrounding brain tissue [3,4]. Secondary brain injury by hematoma often occurs in the days following the initial hemorrhage and is intimately associated with significant neurological deterioration [5].

Up to now, the treatment scheme of AICH especially within the basal ganglia remains a controversial issues among neurologists and neurosurgeons. The results of the International Study of the Treatment of Intracranial Hemorrhage (STICH) corroborates this statement: there was not significant benefit for conventional aggressive surgical treatment over conservative medical treatment for the acute care of ICH [6]. Nevertheless,more than 7000 patients with ICH in the United States ever undergo traditional evacuation procedures each year [7].

Many various clinical studies in recent years all have tested the hypothesis that clot burden plays a significant role in several forms of intracranial hemorrhage, which seem to suggest that clot reduction plays an important role in limiting brain edema and additional neuronal injury, as well as in reducing the severity of neurological deficits following ICH [8-11]. Because of being attributed to the lack of validated therapeutic options for AICH, minimally invasive surgery (MIS) in the treatment of AICH has gained especial attention, and several differrent operation methods emerged over the past decade. In this context, our treatment with a stereotactic technique, which we have termed the minimally invasive stereotactic puncture therapy (MISPT), is herewith presented.

MISPT is a novel operative technique for ICH, which is developed by Pro Jia of China in 1997. Although several clinical studies on MISPT in acute phase of ICH are well recognized in the past decade, the impact of MISPT in short-term and long-term on neurological function of patients who survive the acute phase is less clear. The purpose of the present study was to investigate whether MISPT could maintain long-term benefit as short-term benefit and whether this method could improve ultimate outcomes in these ICH patients. Therefore we compared the long-term outcome one year after treatment obtained in a consecutive series of ICH patients treated by MISPT with the results achieved in a comparable group of patients who were treated by conventional craniotomy (CC).


A prospective controlled study was undertaken. All ICH patients came from in-hospital from 2005 to 2008, diagnosed as ICH according to the ICH criteria of which is drafted by ASA [12]. The clinical trial was in compliance with the WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, and was performed with the approval of our hospital ethics committee (Reference number: JSCS2005058). We generated the sequence for enrolling a subject and allocating the treatment by a randomized number generated by computer. All cases have been monitored in a dedicated stroke unit. Volume of the ICH in milliliters was estimated on the basis of approximate ellipse volume with the A × B × C/2 formula, where A represents the largest diameter of the hematoma on axial CT cuts in centimeters, B the diameter of hematoma perpendicular to A on the same cut, and C the number of CT slices in which hematoma is visible multiplied by the slice thickness in centimeters [13,14].

Inclusion and exclusion criteria for patients

Inclusion criteria were as follows

(1) diagnosed as having spontaneous hemorrhage in the basal ganglion or brain lobe of the brain by CT scan; (2) hemorrhage volume: 30–100 ml; (3) age range: 40–75 years; (4) muscle strength of the paralyzed limbs: grades 0–3 on the muscle strength scale; (5) hemorrhagic duration (from stroke onset to hospital) within 24 h; (6) informed consent from patients and/or their law representative.

Exclusion criteria were as follows

(1) disturbances of blood coagulation, such as thrombocytopenia, hepatitis, etc.; (2) traumatic intracranial hemorrhage; (3) intracranial or general infection; (4) complicated with serious heart, liver, renal or lung disease or functional failure; (5) a previous stroke history with neurological deficits; (6) intracranial aneurysm or arteriovenous malformation complicated with hemorrhage; (7) consent form cannot be obtained from the patient herself or her law representative.

Treatment methods

Minimally invasive stereotactic puncture and thrombolysis therapy (MISPT)

All operations were performed under local anesthesia and intravenous sedation unless the patient was already intubated for medical or neurological indications independent of the procedure. Stereotactic aspiration of the haematomas was performed in the acute phase between the 6th and the 24th hour after onset of stroke refer to MISPT guide. Firstly, the target points was defined according to the computer tomography and mostly target points were chosen in the scan with the largest expansion of the haematoma (shown in Figure 1). Puncture situs was measured and marked on head noticing to get out of the way of main blood vessel, then puncture needle of suitable length (Type YL-1) was fixed on the operative electric drill. The puncture needle was perforated into predetermined depth, then the probe core removed, hematoma drawn out gently by syringe (diluted by saline solution if blood thicken) until 1/3 of hematoma were removed, needle-like hematoma disintegrator inserted. When no more blood could be syringed, the haematoma cavity was thoroughly rinsed with saline, until the saline fluid could be re-aspirated clearly.

thumbnailFigure 1. The slice of the largest hematoma area and puncture point in the CT are illustrated. AB median sagittal line, CD precoronal line, EF lateral sagittal line, P puncture point of hematoma, H center of hematoma, G puncture point of lateral cerebral ventricle, PH puncture depth, L lateral cerebral ventricle.

To confirm gross haematoma evacuation,an immediate postoperative CT scan was taken for assessment of puncture needle placement and residual hematoma volume. If the placement of puncture needle is in the center of hematoma and stable, without rebleeding, the drainage-bag maintained 10 cm upon the head was linked to the puncture needle and switched for drainage. Once rebleeding, 1 ku reptilase or 1 mg adrenalin should be injected into hematoma, drained after 0.5 h, and rinsed after 6-8 h. All patients were administered in a dedicated intensive care unit, where subsequent thrombolysis and clot drainage were performed at the bedside using sterile technique. Hematoma was continuiosly liquefied by liquefacient (containing 20000 U-40000 U urokinase/2-3 mL saline solution) for 2–4 days (3–5 times per day). In the 1st, 3rd, 5th and 7th day of postoperation, patients were re-examined the computer tomography. For haematoma difficulty to aspirate, it should be liquefied as far as possible at first and repeatedly aspirated using agitation manoeuvre of liquefacient to form performance vacuity. Haematoma breaking into one lateral cerebral ventricle should be perforated only haematoma cavity, but for those of haematoma breaking into both lateral cerebral ventricle and casting mould, haematoma cavity and opposite side lateral cerebral ventricle should be perforated simultaneously.

In addition,lumbar puncture could be performed to repeatedly replace cerebral spinal fluid using NS until color pale for 4–5 days (one time per day). When the hematoma was basically cleared or the reminder volume were less than 10 ml, the general condition of patients were stable, and intracranial pressure were normal by lumbar puncture, the puncture needle could be pull out if without intracranial hypertension after drainage tube occluded for 24 h. The puncture needle was removed at the bedside under sterile technique, and a single suture was placed at its exit site and covered with an occlusive dressing. Additionally, all patients received routine medical treatment.

Conventional craniotomy(CC)

After 6-24 h of onset, clearance of hematoma by traditional craniotomy with large bone flap removed was operated in Department of Neurosurgery. The surgery was assessed by postoperative CT to determine if it was successful or not. Meantime, the routine medical treatment was performed.

Complications observation

To comparing its therapeutic effect, several main clinical complications including pulmonary infection, digestive tract hemorrhage and epilepsy were observed two week postoperation. Meanwhile, incidence of complication and rebleeding observation were also carried out.

Follow-up and outcome assessment

Evaluation of all patients followed identical criteria. Initial assessment included baseline characteristics (age, gender, haematoma volume, et al.). The pretreatment clinical state of this cohort was assessed according to the GCS. All cases between two groups could be matched each other with regard to baseline characteristics. The post treatment clinical state of patients was assessed according to the GSC score, incidence of complication, recurrence of bleeding after surgery. Outcome 1 year after stroke was the major endpoint. Four outcome parameters commonly used to assess outcome were employed to study the full impact of haemorrhagic stroke on long-term follow-up. Total case fatality was defined 1 year after stroke. According to the Glasgow Outcome Scale (GOS), clinical outcomes were graded,ranging from good recovery (GOS 5) to dead (GOS 1). The performance and functional status of the patients in activities of daily living (ADL) were measured with the Barthel Index (BI). Handicap was assessed using the modified Rankin Scale (mRS). The datas of all four outcome parameters for two treatment groups were analysed and compared.

Statistical analysis

Categorical variables were analysed using χ2 test or Fisher’s exact test for small numbers. Measurement data were analysed using T-tests. All recorded data were input using Epi Info software and statistically analysed using SPSS 11.5 statistical software. For all analyses, p < 0.05 was considered to be statistically significant.


There were 168 patients analyzed, of which 90 cases were treated with MISPT and 78 cases with CC. There were no statistically significant difference in sex, age, GCS score, localization of bleeding, hemorrhage volume, the level of blood pressure while hospitalization and duration of hypertension in the three groups (shown in Table 1).

Table 1. The baseline characteristics of patients

Comparison of consciousness level after surgery, GCS score and the incidence of complications between the two groups

The GCS score had no significant difference between two groups before operation (8.1 ± 2.3 and 8.4 ± 3.2 respectively, P = 0.523). The total incidence of complication in the MISPT group was lower than that of the CC group (32.3% and 80.7% respectively, P = 0.001). Pulmonary infection (8.9%), digestive tract hemorrhage(17.8%) and epilepsy (5.6%) in the MISPT group were all lower than that of the CC group (21.8%, 39.7% and 19.2%, respectively) (P = 0.029, P = 0.002 and P = 0.036, respectively). The incidence of bleeding recurrence had no significant difference between two groups (10.0% and 15.4% respectively, P = 0.051) (shown in Table 2). According to post-operative imaging findings, about 70-80% of haematoma could be removed in the MISPT group. There were some typical examples in this study. For example, CT scans of one coma patient (GCS score 6) with a huge haematoma (> 70 mL) were shown (Figure 2). It was clear that there were obvious difference in haematoma volume and edema of surrounding brain before MISPT with consciousness of GCS score 5 and 2 weeks after MISPT with consciousness of GCS score 14. The patient achieved self-care living 1 year after on-set (shown in Figure 2).

Table 2. Consciousness level after surgery, GCS score and incidence of complication of two groups

thumbnailFigure 2. CT scans of one patient in a coma (GCS score 6) with a huge haematoma (> 70 mL) before MISPT (upper), and CT scans of the same patient in consciousness (GCS score 14) 2 weeks after completed MISPT with urokinase (lower). All scans demonstrate a series size of hematoma on axial imaging.

Comparison of long-term outcome and total case fatality of two groups 1 year after stroke

Although there was no sharp difference in case fatality between MISPT group and CC group 1 year after stroke(18.9% and 24.4% respectively, P = 0.096), the results showed that the recovery of survival in MISPT group was significantly better than that of the CC group according to the assession results of GOS, mRS and BI(GOS, P = 0.000; mRS, P = 0.001; BI, P = 0.000, respectively). (shown in Table 3).

Table 3. Outcome 1 year after stroke of two groups


The mass effect of hematoma can lead to the brain damage such as intracranial hypertension or cerebral hernia [15]. But there were some evidences shown that the mass effect caused by hematoma volume(< 60 ml) was not the dominant injury mechanism, whereas the toxic substances released from the hematoma were the most important factor in the pathological mechanism of the cerebral hemorrhage [16-18]. It was reported that elevated levels of glutamate were found in the perihematomal region after ICH and were decreased during hematoma drainage. Conversely, ischemic LPRs were not found in perihematomal regions and were unchanged during hematoma drainage. These data suggest that excitotoxicity related to glutamate may have an important impact on secondary injury. The data failed to support the role of ischemia in secondary perihematomal damage [3].

Therefore, effective removal of hematoma at the acute phase is the crucial principle of treatment with ICH for saving life and improving the long-term quality of life. CC by removing bone flap is the classical technique treating ICH which is characterized by good view, clearance of hematoma completely, easy haemostasia, and the entire reduction of pressure,but also have some shortcomings such as taking long time to operate, damaging brain severely, being subject to pulling the brain in the operation, the brain tissue around the hematoma readily damaged by electrocoagulation, re-bleeding readily, producing a series of pathophysiological changes in post-operation (such as disturbance of water and electrolyte, fluctuation of blood sugar, instability of life signs and so on), which resulting in severe impairment of neurological function, multiple complications, higher invalidism rate and fatality rate. With regard to basal ganglia haemorrhages, comparing the outcome of patients treated surgically with that of patients managed conservatively, many earlier and current publications showed no benefit from conventional surgery [6,7,19-22]. Correspondly this disappointing results, only a few reports have demonstrated a trend towards better outcomes in conventional surgical group [23-25]. While analysing the given data, it becomes obvious that the major problem in all these studies is the heterogeneity of the ICH patient groups with regard to their preoperative neurological status with quite different degrees of neurological impairment and not uniform consciousness levels, applying different surgical approaches and different intervals with regard to the onset of haemorrhagic stroke. Thus it is an essential issue to select appropriate patients and homogenous group for determining whether patients truly benefit from neurosurgical or not treated by stereotactic evacuation of the haematomas in the acute phase. In many recent studies the minimally-invasive method have shown to be highly efficient with little risk of re-bleeding and better short-term outcome [26-28]. Presently, some clinicians are exploring new methods to elevate curative effect of minimally-invasive operation technique. A study by Marquardt and coworkers focused on the use of a novel multiple target aspiration technique in 64 patients to aspirate a “sufficient proportion” of the hematoma with minimal risk for the patient. More than 80% of the hematoma volume was successfully aspirated in 73.4% of the patients with only one episode of re-bleeding [29]. Jose’s study showed that CT-guided thrombolysis and aspiration was safe and effective in the reduction of ICH volume. But meantime they proposed further studies were needed to assess optimal thrombolytic dosage and must include controlled comparisons of mortality, disability outcome time until convalescence, and cost of care in treated and untreated patients [30].

MISPT is a new and novel operative technique obviously differrent from other various kinds minimally-invasive operations in design principle, which is developed by Pro Jia from China in 1994 with a distinctive thrombolysis installation, and highly safe and efficient functions of dissolving and draining coagulated blood. This treatment had been widely applied in China. According to some study in the past, it was presented that MISPT in acute ICH could efficiently clear hematoma, relieve hydrocephalus, drop the intracranial hypertension, and relieve the cytotoxicity of blood thrombin. Furthermore, the washing liquor could decrease the cytotoxic substances. In subacute hemorrhage, MISPT could reduce the neurotoxicity of the hemoglobin and its disaggregation such as ferri ion. This technique is characterized by its simple operation, not limited by equipment. The puncture of MISPT is little harmful for the brain, and profit the recovery of cerebral function, and the liquefaction technique contribute to the blood coagulum liquefied, which all help shorten the course of disease. In the whole procedure of the operation, patients were only treated with the puncture of 3 mm needle in diameter. Because of no gap between the needle and skull, which reduce the incidence of infection. Furthermore, it is not needed to open the skull and anesthetize generally, and being cheaper than other operations. Chinese National Research and Extension Community of the Minimally Invasive Operation suggested that MISPT is suitable to the cases that have hemorrhage volume > 30 mL in basal ganglia,and further standardize the operation indication, operation procedure and the applying methods of the hematoma liquefacient according to the random sampling of The Ministry of Public Health [31].

Although there being many studies to investigate the minimally invasive operation indication of ICH, few specially concerned indicatio of the MISPT. Furthermore, most of these investigations didn’t establish the control groups strictly with uniform baseline characteristics patients on preoperation, analyze the correlation factors such as GCS score, hematoma volume, haematoma location, duration of BP and observe the long-term outcome for survival. In our study, above shortcomings in research were overcame with many factors being considered including preoperative neurological status, surgical approaches and opportunity applied, GCS score, incidence of complication and rebleeding incidence after surgery, long-term outcome 1 year after onset and so on. The result showed that the level of consciousness and GCS in MISPT were better than that of the CC group. There were 17 cases died in 20 patients with 4–5 GCS score in two groups (the ratio is 85.0%), the 3 survivor all treated with MISPT (Table 1, one case referring to Figure 2). The incidence of complications such as pulmonary infection, hemorrhage of digestive tract, and epilepsy in MISPT was obviously reduced compare to CC group. There were no cases of intracranial infection both in MISPT and the craniotomy group. The statistical analysis did not show the significant difference on the rebleeding incidence in the two groups (10.0% and 15.4% respectively, P = 0.151). There were no obviously difference between the case fatalities of MISPT group and CC group (18.9% and 24.4% respectively, P = 0.096). The long-term outcome of MISPT group surpassed over that of CC group according to the results of GOS, mRS and BI. (GOS, P = 0.000; mRS, P = 0.001; BI, P = 0.000).

In present, there were some exploration on thrombolysis methods. We used UK as thrombolysis methods in our MISPT study. Otherwise, in another cohort of ICH patients treated using FAST, volumetric analysis of ICH and perihematomal edema seems to suggest that local use of rtPA as thrombolysis which differed from UK used in our MISPT does not exacerbate brain edema formation. Furthermore, there seems to be a strong association between reduction in ICH volume and reduction in edema volume, as would be expected following the concept of “hemotoxicity” postulated by some investigators [32].

These above clinical study results suggested that the AICH patient fitting to operation indication should choose MISPT rather than CC, however, excluding those patient with huge hemorrhage volume,or the state of illness progress rapidly, or in the early state of cerebral hernia who should select the craniotomy to rapidly reduce the cerebral pressure. Otherwise, some study have point out that although MIS on the patients with cerebral hernia may not get good curative effect, which can decrease the hematoma volume partly and reduce the intracranial pressure rapidly, and gain time for craniotomy [30]. Of course, CC has also its superiority especaily in treating ICH with bulk volume. 12 patients with hemorrhage volume > 60 ml in the right hemisphere were operated by the reduction pressure of removal bone flag and the clearance of hematoma. 11 patients survived (92% of the survival rate), and 6 cases of the survivors recovered well [33].

Although our- larger randomized trials on MISPT treatment benefits over conventional craniotomy (CC) or purely medical treatment(PMT) are in process and have not come to conclusion yet. At present, our preliminary study data on MISPT comed out with optimistic results superior over CC or PMT. Several methodological issues surrounding MISPT remain to be resolved, including formulating strict operation indication, optimizing- technological process, screening better clot thrombolysis preparation and comparison of the relative efficacies of various drainage methods. If successful, MISPT perhaps becomes an important treatment tool for those ICH patients. We hope that this ongoing study will bring us closer to other randomized trials regarding to more relevant factors with MISPT as an alternative treatment for ICH. Of course, proper selection of the ICH patient to apply MISPT may hold the key to these advances. Otherwise, objectively, MISPT is not under direct vision and is limited in the ability of achieving hemostasis and completely evacuating the hematoma.


These data indicated that the advantage of MISPT compared with conventional craniotomy was not only displayed in short-term outcome such as minute trauma and safety, but also seemed to be feasible and had a trend towards improved long-term outcome such as the GOS,BI and mRS.


ICH: Intracerebral hemorrhage; MISPT: Minimally invasive stereotactic puncture therapy; CC: Conventional craniotomy; GCS: Glasgow Coma Scale; PC: Postoperative complications; RI: Rebleeding incidence; GOS: Glasgow Outcome Scale; BI: Barthel Index; MRS: Modified Rankin Scaleand; CF: Case fatality.

Competing interests

All authors declare that there is not any financial competing interests.

Authors' contributions

ZHG, ZY and DQ conceived of the study, drew up the study’s design and coordination,performed the statistical analysis and drafted the manuscript. LL, HW and XJZ conducted the minimally invasive stereotactic puncture therapy and conventional craniotomy in clinical work. HX and TYP helped to draft the manuscript. TYH participated in the study’s design and statistical analysis. All authors read and approved the final manuscript.

Authors' information

Yu Zhang Co-first author.


  1. Fayad PB, Awad IA: Surgery for intracerebral hemorrhage.

    Neurology 1998, 51(Suppl 3):S69-S73. OpenURL

  2. Flaherty ML, Haverbusch M, Sekar P, et al.: Long-term mortality after intracerebral hemorrhage.

    Neurology 2006, 66(8):1182-1186. OpenURL

  3. Miller CM, Vespa PM, McArthur DL, et al.: Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduced levels of extracellular cerebral glutamate and unchanged lactate pyruvate ratios.

    Neurocrit Care 2007, 6(1):22-29. OpenURL

  4. Wu JM, Hua Y, Keep RF, et al.: Iron and iron-handling proteins in the brain after intracerebral hemorrhage.

    Stroke 2003, 34(12):2964-2969. OpenURL

  5. Xi GH, Keep RF, Hoff JT: Pathophysiology of brain edema formation.

    Neurosurg Clin N Am 2002, 13(3):371-383. OpenURL

  6. Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.

    Lancet 2005, 365(9457):387-397. OpenURL

  7. Juvela S, Heiskanen O, Poranen A, et al.: The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment.

    J Neurosurg 1989, 70(5):755-758. OpenURL

  8. Wagner KR, Xi GH, Hua Y, et al.: Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood–brain barrier protection.

    J Neurosurg 1999, 90(3):491-498. OpenURL

  9. Teernstra OPM, Evers SMAA, Lodder J, et al.: Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator - a multicenter randomized controlled trial (SICHPA).

    Stroke 2003, 34(4):968-974. OpenURL

  10. Vespa P, McArthur D, Miller C, et al.: Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement.

    Neurocrit Care 2005, 2(3):274-281. OpenURL

  11. Miller DW, Barnett GH, Kormos DW, et al.: Stereotactically guided thrombolysis of deep cerebral hemorrhage: preliminary results.

    Cleve Clin J Med 1993, 60(4):321-324. OpenURL

  12. Broderick J, Connolly S, Feldmann E, et al.: Guidelines for the management of spontaneous intracerebral Hemorrhage in adults - 2007 update - A guideline from the American Heart Association/American Stroke Association Stroke Council, high blood pressure research council, and the quality of care and outcomes in research interdisciplinary working group-The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

    Stroke 2007, 38(6):2001-2032. OpenURL

  13. Brott T, Broderick J, Kothari R, et al.: Early growth in patients with intracerebral hemorrhage.

    Stroke 1997, 28(1):1-5. OpenURL

  14. Kothari U, Brott T, Broderick JP, et al.: The ABCs of measuring intracerebral hemorrhage volumes.

    Stroke 1996, 27(8):1304-1305. OpenURL

  15. Belayev L, Saul I, Curbelo K, et al.: Experimental intracerebral hemorrhage in the mouse - Histological, behavioral, and hemodynamic characterization of a double-injection model.

    Stroke 2003, 34(9):2221-2227. OpenURL

  16. Rabinstein AA, Atkinson JL, Wijdicks EFM: Emergency craniotomy in patients worsening due to expanded cerebral hematoma-To what purpose?

    Neurology 2002, 58(9):1367-1372. OpenURL

  17. Huang FP, Xi GH, Keep RF, et al.: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products.

    J Neurosurg 2002, 96(2):287-293. OpenURL

  18. Georgiadis P, Xu HM, Chua C, et al.: Characterization of acute brain injuries and neurobehavioral profiles in a rabbit model of germinal matrix hemorrhage.

    Stroke 2008, 39(12):3378-3388. OpenURL

  19. Sykora M, Diedler J, Juttler E, et al.: Intensive care management of acute stroke: surgical treatment.

    Int J Stroke 2010, 5(3):170-177. OpenURL

  20. McKissock W, Taylor J, Richardson A: Primary intracerebral hemorrhage: a controlled trial of surgical and conservative treatment in 180 unselected cases.

    Lancet 1961, 2(719):221-226. OpenURL

  21. Elliott J, Smith M: The acute management of intracerebral hemorrhage: a clinical review.

    Anesth Analg 2010, 110(5):1419-1427. OpenURL

  22. Tan SH, Ng PY, Yeo TT, et al.: Hypertensive basal ganglia hemorrhage: a prospective study comparing surgical and nonsurgical management.

    Surg Neurol 2001, 56(5):287-292. OpenURL

  23. Hankey GJ, Hon C: Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials.

    Stroke 1997, 28:2126-2132. OpenURL

  24. Peng SY, Chuang YC, Kang TW, et al.: Random forest can predict 30-day mortality of spontaneous intracerebral hemorrhage with remarkable discrimination.

    Eur J Neurol 2010, 17(7):945-950. OpenURL

  25. Rincon F, Mayer SA: Intracerebral hemorrhage: getting ready for effective treatments.

    Curr Opin Neurol 2010, 23(1):59-64. OpenURL

  26. Barrett RJ, Hussain R, Coplin WM, et al.: Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage.

    Neurocrit Care 2005, 3(3):237-245. OpenURL

  27. Marquardt G, Wolff R, Janzen RWC, et al.: Basal ganglia haematomas in non- comatose patients: subacute stereotactic aspiration improves long-term outcome in comparison to purely medical treatment.

    Neurosurg Rev 2005, 28(1):64-69. OpenURL

  28. Marquardt G, Wolff R, Sager A, et al.: Subacute stereotactic aspiration of hematomas within the basal ganglia reduces occurrence of complications in the course of hemorrhagic stroke in non-comatose patients.

    Cerebrovasc Dis 2003, 15(4):252-257. OpenURL

  29. Marquardt G, Wolff R, Seifert V: Multiple target aspiration technique for subacute stereotactic aspiration of hematomas within the basal ganglia.

    Surg Neurol 2003, 60(1):8-13. OpenURL

  30. Montes JM, Wong JH, Fayad PB, et al.: Stereotactic computed tomographic– guided aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience.

    Stroke 2000, 31(4):834-840. OpenURL

  31. Liu HM, Wang WZ, Li D: A randomized controlled study on comparison between two kinds of operations in treating intracerebral hemorrhage.


  32. Carhuapoma JR, Barrett RJ, Keyl PM, et al.: Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.

    Neurocrit Care 2008, 8(3):322-329. OpenURL

  33. Murthy JMK, Chowdary GVS, Murthy TVRK, et al.: Decompre- ssive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage.

    Neurocrit Care 2005, 2(3):258-262. OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here: